Regulatory Mechanisms Driving the Overlap of Elemental Leachables and ICH Q3D The principal intersection between elemental leachables and the toxicological […]
Elemental Leachables and ICH Q3D: How the Two Guidelines Overlap Read More »
Introduction to Extractables and Leachables Thresholds in Impurity Control Extractables and leachables thresholds are scientifically established safety limits used to
Summary: Introduction: Why PLGA Analytical Data for Injectable Use Demands a Higher Standard When procuring poly(lactic-co-glycolic acid) for parenteral formulations,
What Analytical Data Should You Request When Buying PLGA for Injectable Use? Read More »
Introduction A comprehensive peptide purity testing report must include validated chromatographic and mass spectrometric data to verify both chemical sequence
GC-MS vs LC-MS/MS for Nitrosamine Testing: How to Choose the Right Analytical Technique Read More »
Modern Analytical Platforms for Peptide Mapping and Sequence Analysis This section explains how high-resolution mass spectrometry combined with liquid chromatography
Peptide Mapping and Sequence Analysis Services for Biosimilars Read More »
The assessment of Extractables and Leachables (E&L) in biologic drug products remains one of the most significant safety and quality
Extractables and Leachables in Biologic Drug Products: Mass Spectrometry Approaches Read More »
Introduction: The convergence of peptide chemistry and oligonucleotide biology has produced one of the most promising — and analytically demanding
Introduction Selecting Low-Leachables Packaging Materials for critical pharmaceutical and biopharmaceutical systems requires a structured, science-driven assessment of polymer thermodynamics, migration
How to Select Materials for Low-Leachables Packaging Systems Read More »
Understanding Why Biosimilars Fail Regulatory Approval: An Analytical Overview Biosimilars fail regulatory approval primarily because of deficiencies in chemistry, manufacturing,
Why Do Some Biosimilars Fail Regulatory Approval? The Most Common Development Pitfalls Read More »
Introduction: Understanding which analytical tests for biosimilar regulatory submission are mandatory is one of the most complex challenges in biologic drug development.
What Analytical Tests Are Mandatory for a Biosimilar Regulatory Submission? Read More »
